New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:37 EDTCPHDCepheid upgraded at Needham
As previously reported, Needham upgraded Cepheid to Buy from Hold. The firm upgraded shares based on expectations for faster growth driven by recent international launches of HPV and Norovirus, virology expansion, and U.S. sales management changes that should driver faster growth. Price target is $50.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2015
10:00 EDTCPHDOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AcelRx (ACRX) initiated with a Buy at H.C. Wainwright... Adobe (ADBE) initiated with a Perform at Oppenheimer... Antero Midstream (AM) initiated with a Buy at Ladenburg... Arbutus Biopharma (ABUS) initiated with an Outperform at JMP Securities... CSI Compressco (CCLP) initiated with a Market Perform at Wells Fargo... Cepheid (CPHD) initiated with an Equal Weight at Barclays... Cincinnati Financial (CINF) initiated with a Buy at MKM Partners... Disney (DIS) initiated with an Outperform at CLSA... Genomic Health (GHDX) initiated with an Underweight at Barclays... Green Brick (GRBK) initiated with a Neutral at Citi... Heron Therapeutics (HRTX) initiated with a Buy at BofA/Merrill... Karyopharm (KPTI) initiated with an Overweight at JPMorgan... PayPal (PYPL) initiated with a Buy at Argus... Quidel (QDEL) initiated with an Overweight at Barclays... Recro Pharma (REPH) initiated with a Buy at H.C. Wainwright.
09:17 EDTCPHDBarclays life science analysts hold an analyst/industry conference call
Subscribe for More Information
05:28 EDTCPHDCepheid initiated with an Equal Weight at Barclays
Subscribe for More Information
August 25, 2015
09:43 EDTCPHDCepheid issued warning letter from FDA following site inspection
Subscribe for More Information
August 24, 2015
08:29 EDTCPHDWilliam Blair to hold a field trip
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use